These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8196321)

  • 1. [Gemfibrozil in the treatment of lipid metabolism disorders].
    Vartanova OA; Aleksandrovskaia TN; Shaldaeva VV
    Klin Med (Mosk); 1994; 72(1):37-41. PubMed ID: 8196321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemfibrozil in hyperlipidaemia: an open, single blind trial.
    Varthakavi PK; Turakhia DP; Sharma SS; Salgaonkar DS; Nihalani KD; Joshi VR
    J Assoc Physicians India; 1990 Feb; 38(2):136-40. PubMed ID: 2380132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison between lovastatin and gemfibrozil in treatment of primary hyperlipidemias].
    Bertolami MC; Martinez TL; Faludi AA; Pinto LE; Melo RS; Bismarck ZF; Batlouni M
    Arq Bras Cardiol; 1991 May; 56(5):407-12. PubMed ID: 1823741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia].
    Corominas Vilardell A; de Oya Otero M; Escobar Jiménez F; Anguera Vila A; Ariño Armengol B
    An Med Interna; 1993 Nov; 10(11):537-41. PubMed ID: 8117868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemfibrozil in dyslipidaemia.
    Kundu SC; Roxy S; Batabyal SK
    J Assoc Physicians India; 1990 Feb; 38(2):156-9. PubMed ID: 2199426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
    Wolf HR
    Drugs Exp Clin Res; 1994; 20(3):109-13. PubMed ID: 7956717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gemfibrozil on composition of lipoproteins and distribution of LDL subspecies.
    Tsai MY; Yuan J; Hunninghake DB
    Atherosclerosis; 1992 Jul; 95(1):35-42. PubMed ID: 1642690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gemfibrozil in the treatment of hyperlipidemia].
    Wang JJ; Song YM; Wang YS; Lin WH
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):131-4. PubMed ID: 2766068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gemfibrozil in the differential therapy of disorders of fat metabolism].
    Ebner F
    Fortschr Med; 1992 Oct; 110(28):523-6. PubMed ID: 1398412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
    Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemfibrozil treatment increases low-density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizability.
    O'Neal DN; O'Brien RC; Timmins KL; Grieve GD; Lau KP; Nicholson GC; Kotowicz MA; Best JD
    Diabet Med; 1998 Oct; 15(10):870-7. PubMed ID: 9796889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients.
    Seyoum B; Abdulkadir J; Berhanu P; Feleke Y; Mengistu Z; Worku Y; Ayana G
    Ethiop Med J; 2003 Jan; 41(1):1-8. PubMed ID: 12764995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia.
    Lewis JE
    Angiology; 1982 Sep; 33(9):603-12. PubMed ID: 6957156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gemfibrozil (Lopid) on hyperlipidemia in acitretin-treated patients. Results of a double-blind cross-over study.
    Vahlquist C; Olsson AG; Lindholm A; Vahlquist A
    Acta Derm Venereol; 1995 Sep; 75(5):377-80. PubMed ID: 8615057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
    Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gemfibrozil: new aspects in clinical use].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():625-30. PubMed ID: 11347143
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB; Donega P; Passaro A; Zanca R; Cattin L; Fonda M; Pauciullo P; Marotta G; Fellin R; Gasparrini S; Piliego T
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of gemfibrozil on serum lipids in man.
    Fenderson RW; Deutsch S; Menachemi E; Chin B; Samuel P
    Angiology; 1982 Sep; 33(9):581-93. PubMed ID: 6751166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamin E and gemfibrozil on lipid profiles, lipid peroxidation and antioxidant status in the elderly and young hyperlipidemic subjects.
    Sutken E; Inal M; Ozdemir F
    Saudi Med J; 2006 Apr; 27(4):453-9. PubMed ID: 16598319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.